T cell derived HB-EGF prevents Th17 cell differentiation in an autocrine way (2021)

First Author: Macdonald F
Attributed to:  Use of EGF-R antagonists for the treatment of infections and tumour growth funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.02.09.430418

Publication URI: http://dx.doi.org/10.1101/2021.02.09.430418

Type: Preprint